Published in Clin Obstet Gynecol on December 01, 2013
Premenopausal Osteoporosis. Endocrinol Metab Clin North Am (2016) 0.75
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) (2010) 4.65
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med (1998) 4.38
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med (1997) 4.18
Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol (1996) 2.76
Bone gain in young adult women. JAMA (1992) 2.73
Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract (2001) 1.81
Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab (2005) 1.68
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int (2000) 1.62
Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int (2006) 1.52
The annual incidence and seasonal variation of fractures of the distal radius in men and women over 25 years in Dorset, UK. Injury (2004) 1.47
Epidemiology and clinical features of osteoporosis in young individuals. Bone (1995) 1.31
Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. JAMA (1998) 1.30
Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab (2006) 1.27
Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2011) 1.11
Fractures before menopause: a red flag for physicians. Osteoporos Int (2002) 1.07
Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology (1999) 1.07
Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev (2003) 1.06
Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures. Arch Intern Med (2002) 1.03
Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density. Osteoporos Int (2011) 1.03
Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab (2011) 1.02
Pharmacovigilance study of alendronate in England. Osteoporos Int (2003) 1.01
Pregnancy outcome following in utero exposure to bisphosphonates. Bone (2008) 0.98
Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab (2013) 0.98
Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol (1993) 0.95
Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab (2006) 0.94
Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status. Osteoporos Int (2009) 0.94
Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum (2002) 0.94
Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause. Clin Orthop Relat Res (2005) 0.93
Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up. Br J Rheumatol (1994) 0.91
A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate. J Clin Endocrinol Metab (2003) 0.91
Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab (2004) 0.90
Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review. Br J Sports Med (2006) 0.90
Idiopathic osteoporosis in premenopausal women. Osteoporos Int (2004) 0.90
Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities. Clin Exp Rheumatol (2009) 0.89
Quantitative ultrasound: use in screening for susceptibility to stress fractures in female army recruits. J Bone Miner Res (2004) 0.89
Effect on bone health of estrogen preparations in premenopausal women with anorexia nervosa: a systematic review and meta-analyses. Int J Eat Disord (2010) 0.89
Lifestyle influences on 9-year changes in BMD in young women. J Bone Miner Res (2004) 0.89
Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis. Clin Rheumatol (2006) 0.89
Maternity and bone mineral density. Acta Orthop (2005) 0.87
The role of exercise in the treatment of osteoporosis. Curr Osteoporos Rep (2010) 0.85
Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int (1997) 0.84
Treatment of premenopausal women with low bone mineral density. Curr Osteoporos Rep (2008) 0.84
Oral pamidronate prevents high-dose glucocorticoid-induced lumbar spine bone loss in premenopausal connective tissue disease (mainly lupus) patients. Lupus (2005) 0.83
Premenopausal bone health assessment. Curr Rheumatol Rep (2005) 0.82
Peripheral bone mineral density in patients with distal radial fractures. J Bone Joint Surg Br (2003) 0.81
Treatment of glucocorticoid-induced osteoporsis. Ther Adv Musculoskelet Dis (2009) 0.76
Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med (2007) 7.60
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76
High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol (2009) 2.97
Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol (2008) 2.87
Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res (2010) 2.37
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy. J Allergy Clin Immunol (2010) 2.22
Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis (2010) 2.20
The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab (2008) 2.12
High-resolution peripheral quantitative computed tomography can assess microstructural and mechanical properties of human distal tibial bone. J Bone Miner Res (2010) 2.01
Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol (2006) 1.91
Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab (2013) 1.88
Short-term bone loss in HIV-infected premenopausal women. J Acquir Immune Defic Syndr (2010) 1.87
Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res (2011) 1.86
Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res (2010) 1.78
Chronic kidney disease and bone fracture: a growing concern. Kidney Int (2008) 1.76
Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res (2013) 1.74
Bone fragility and collagen cross-links. J Bone Miner Res (2004) 1.68
Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2009) 1.61
Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res (2009) 1.54
Bone density, geometry, microstructure, and stiffness: Relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and cQCT in premenopausal women. J Bone Miner Res (2010) 1.50
Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes. Kidney Int (2013) 1.48
Management of bone loss after organ transplantation. J Bone Miner Res (2004) 1.46
Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure. J Heart Lung Transplant (2008) 1.46
Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res (2008) 1.46
Individual trabeculae segmentation (ITS)-based morphological analysis of high-resolution peripheral quantitative computed tomography images detects abnormal trabecular plate and rod microarchitecture in premenopausal women with idiopathic osteoporosis. J Bone Miner Res (2010) 1.46
Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) (2009) 1.44
Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation. Eur J Heart Fail (2012) 1.43
Prevention of fractures after solid organ transplantation: a meta-analysis. J Clin Endocrinol Metab (2011) 1.41
Individual trabecula segmentation (ITS)-based morphological analyses and microfinite element analysis of HR-pQCT images discriminate postmenopausal fragility fractures independent of DXA measurements. J Bone Miner Res (2012) 1.40
Bone mass and mineral metabolism in HIV+ postmenopausal women. Osteoporos Int (2005) 1.40
Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab (2003) 1.38
Growth and skeletal maturation after pediatric cardiac transplantation. Pediatr Transplant (2004) 1.38
Osteonecrosis of the jaw: more research needed. J Bone Miner Res (2006) 1.36
Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol (2008) 1.36
The prevalence and natural course of food protein-induced enterocolitis syndrome to cow's milk: a large-scale, prospective population-based study. J Allergy Clin Immunol (2011) 1.34
PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res (2011) 1.30
Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol (2010) 1.26
Benefits and risks of bisphosphonate therapy for osteoporosis. J Clin Endocrinol Metab (2012) 1.24
Individual trabecula segmentation (ITS)-based morphological analysis of microscale images of human tibial trabecular bone at limited spatial resolution. J Bone Miner Res (2011) 1.24
Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics (2009) 1.22
Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study. AIDS (2010) 1.19
Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women. J Bone Miner Res (2013) 1.17
Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss. Metabolism (2011) 1.17
Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women. J Clin Endocrinol Metab (2009) 1.16
Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study. J Clin Endocrinol Metab (2011) 1.16
Three dimensional cancellous bone structure in hypoparathyroidism. Bone (2009) 1.12
Abnormal microarchitecture and stiffness in postmenopausal women with ankle fractures. J Clin Endocrinol Metab (2011) 1.12
Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2011) 1.11
Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol (2005) 1.11
Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2005) 1.06
Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol (2011) 1.05
Multicenter precision of cortical and trabecular bone quality measures assessed by high-resolution peripheral quantitative computed tomography. J Bone Miner Res (2013) 1.02
Evolving data about subtrochanteric fractures and bisphosphonates. N Engl J Med (2010) 1.02
Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism. Bone (2010) 1.01
Bone material properties in premenopausal women with idiopathic osteoporosis. J Bone Miner Res (2012) 1.00
Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment. J Clin Endocrinol Metab (2009) 0.99
Skeletal structure in postmenopausal women with osteopenia and fractures is characterized by abnormal trabecular plates and cortical thinning. J Bone Miner Res (2014) 0.98
Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab (2013) 0.98
Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int (2003) 0.97
Prolonged hypocalcemia after treatment with zoledronic acid in a patient with prostate cancer and vitamin D deficiency. J Clin Oncol (2004) 0.96
Increased marrow adiposity in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2012) 0.96
Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study. J Clin Endocrinol Metab (2014) 0.94
Clinical imaging of bone microarchitecture with HR-pQCT. Curr Osteoporos Rep (2013) 0.94
Secondary osteoporosis. Endocrinol Metab Clin North Am (2003) 0.94
Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial. Am J Clin Nutr (2012) 0.94
Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav (2003) 0.93
Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures. J Clin Endocrinol Metab (2012) 0.93
Post-transplantation osteoporosis. Endocrinol Metab Clin North Am (2007) 0.91
Insights from the conduct of a device trial in older persons: low magnitude mechanical stimulation for musculoskeletal health. Clin Trials (2010) 0.90
Osteoporosis after solid organ transplantation. J Clin Endocrinol Metab (2004) 0.90
Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS (2014) 0.90
Idiopathic osteoporosis in premenopausal women. Osteoporos Int (2004) 0.90
The impact of environmental tobacco smoke on women's risk of dying from heart disease: a meta-analysis. J Womens Health (Larchmt) (2004) 0.89
Site-specific changes in bone microarchitecture, mineralization, and stiffness during lactation and after weaning in mice. J Bone Miner Res (2012) 0.89
Longitudinal HR-pQCT and image registration detects endocortical bone loss in kidney transplantation patients. J Bone Miner Res (2015) 0.89
Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. J Heart Lung Transplant (2006) 0.88
Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center. J Womens Health (Larchmt) (2009) 0.88
Natural course and risk factors for persistence of IgE-mediated cow's milk allergy. J Pediatr (2012) 0.86
Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control (2014) 0.86
Low bone-mineral density in patients with HIV: pathogenesis and clinical significance. Curr Opin Endocrinol Diabetes (2006) 0.85
Central QCT reveals lower volumetric BMD and stiffness in premenopausal women with idiopathic osteoporosis, regardless of fracture history. J Clin Endocrinol Metab (2012) 0.85
Fast trabecular bone strength predictions of HR-pQCT and individual trabeculae segmentation-based plate and rod finite element model discriminate postmenopausal vertebral fractures. J Bone Miner Res (2013) 0.84
Treatment of premenopausal women with low bone mineral density. Curr Osteoporos Rep (2008) 0.84
Metabolic bone disease in human immunodeficiency virus-infected children. J Clin Endocrinol Metab (2004) 0.84
Bone quality determined by Fourier transform infrared imaging analysis in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2008) 0.83
Osteoporosis in diffuse parenchymal lung disease. Chest (2006) 0.83
Effect of renal function on skeletal health in primary hyperparathyroidism. J Clin Endocrinol Metab (2012) 0.83
Clinical assessment of the 1/3 radius using a new desktop ultrasonic bone densitometer. Ultrasound Med Biol (2013) 0.82
Severe vitamin D deficiency among heart and liver transplant recipients. Clin Transplant (2009) 0.82